Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases

Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases

Parkinson's disease is a neurodegenerative disorder characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta region (SNpc) of the brain. Although, FDA-approved therapeutic agents are available for the treatment of Parkinson's disease. However, the per...

Full description

Bibliographic Details
Main Authors: Anjali Bhosale, Gajanan Paul, Farhan Mazahir, A.K. Yadav
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:OpenNano
Subjects:
Neurodegeneration
Parkinson's disease
Blood–Brain Barrier (BBB)
Nanocarriers
Lewy bodies
Online Access:http://www.sciencedirect.com/science/article/pii/S2352952022000731

Internet

http://www.sciencedirect.com/science/article/pii/S2352952022000731

Similar Items